Engineering Stem Cell Organoids|
The authors discuss basic approaches to generate stem cell-based organoids, their advantages and limitations, and how bioengineering strategies can be used to steer the cell composition and their 3D organization within organoids to further enhance their utility in research and therapies. [Cell Stem Cell] Abstract
Visit our reviews page to see a complete list of reviews in the intestinal cell research field.
Researcher Gets Grant to Study How Immune System Can Prevent Inflammatory Bowel Diseases|
A Georgia State University researcher has received a private grant of nearly $300,000 to investigate how the immune system can prevent inflammatory bowel disease. Benoit Chassaing, assistant professor in the Institute for Biomedical Sciences, will study how the adaptive immune system, which protects the body against pathogens, can control intestinal bacteria to prevent inflammation in the gut. [Georgia State University] Press Release
Takeda and enGene Establish Strategic Alliance to Develop Novel Therapeutics for Gastrointestinal Diseases
Takeda Pharmaceutical Company Ltd. and enGene, Inc. announced a strategic alliance to discover, develop and commercialize novel therapies for specialty gastrointestinal diseases using enGene’s “Gene Pill” gene delivery platform. [Takeda Pharmaceutical Company Ltd.] Press Release
GE Healthcare, FedDev Ontario Commit CAD $40 Million for New CCRM-Led Centre to Solve Cell Therapy Manufacturing Challenges
GE Healthcare, the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), and the Centre for Commercialization of Regenerative Medicine (CCRM) are building a centre for advanced therapeutic cell technologies in Toronto with an investment of $40 million from GE and FedDev Ontario. [Centre for Commercialization of Regenerative Medicine] Press Release
From our sponsor:
Discover how to reduce variability in primary neuron cultures with NeuroCult™ SM. Watch the webinar.